Combined anti-PD-1, HDAC inhibitor and anti-VEGF for MSS/pMMR colorectal cancer: a randomized phase 2 trial
Feng Wang(Sun Yat-sen University), Rui‐Hua Xu(Sun Yat-sen University), Weijia Fang(First Affiliated Hospital Zhejiang University), Jibin Li(Chongqing Public Health Medical Center), Min Wang(Sun Yat-sen University), Zixian Wang(Sun Yat-sen University), Ying Jin(Chinese Academy of Sciences), Qi Zhao(Sun Yat-sen University), Yan‐Xing Chen(Sun Yat-sen University), Yanqiao Zhang(Harbin Medical University), Wen‐Long Guan(Sun Yat-sen University), Miao‐Zhen Qiu(Sun Yat-sen University), Yuhong Li(Sun Yat-sen University), Lulu Liu(Affiliated Hospital of Jining Medical University), Zhi‐Qiang Wang(Sun Yat-sen University), Feng‐Hua Wang(Sun Yat-sen University), Chao Ren(Sun Yat-sen University), Hui Luo(Sun Yat-sen University), Lin Tian(Sichuan University), Xiaohua Hu(Guangxi Medical University), Yingnan Wang(Sun Yat-sen University), Run-Jie Huang(Sun Yat-sen University), Dong‐Sheng Zhang(Sun Yat-sen University), Wenting Liao(Sun Yat-sen University), De‐Shen Wang(Sun Yat-sen University)
Cited by 162
Related Papers
Circular RNA: metabolism, functions and interactions with proteins
|Molecular Cancer|2020|1.6k
IBS: an illustrator for the presentation and visualization of biological sequences
|Bioinformatics|2015|1.1k
Gemcitabine and Cisplatin Induction Chemotherapy in Nasopharyngeal Carcinoma
|New England Journal of Medicine|2019|934
METTL3 facilitates tumor progression via an m6A-IGF2BP2-dependent mechanism in colorectal carcinoma
|Molecular Cancer|2019|868